C. Walsh et al., PATERNALLY DERIVED H19 IS DIFFERENTIALLY EXPRESSED IN MALIGNANT AND NONMALIGNANT TROPHOBLAST, Cancer research, 55(5), 1995, pp. 1111-1116
The paternal allele of the H19 gene has been shown to be transcription
ally inactive in the developing human embryo. Using reverse transcript
ion PCR and RNase protection assays, we demonstrate that expression of
H19 is predominantly, but not exclusively, from the maternal allele i
n the human placenta. In situ hybridization analysis shows strong expr
ession of the H19 gene in eight complete hydatidiform moles, hyperplas
tic tissues consisting of trophoblasts which contain only paternally d
erived genetic material, indicating that H19 is not functionally impri
nted in this tissue. H19, a putative growth suppressor, is oppositely
imprinted to the neighboring insulin-like growth factor II (IGF2) gene
and an up-regulation of IGF2 expression has been linked previously to
a down-regulation of H19 expression in the progression to Wilms' tumo
r. Two cases of complete hydatidiform mole which progressed to chorioc
arcinoma show high levels of expression of both H19 and IGF2. The chor
iocarcinomas which developed from these complete hydatiform moles show
ed similar expression of IGF2 but a decreased number of H19-positive c
ells, which may reflect selection for cells expressing IGF2 and agains
t those expressing H19 in this tissue.